• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞氏葡萄膜炎视力丧失的模式及原因:短期和长期预后

Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.

作者信息

Amer Radgonde, Alsughayyar Walaa, Almeida Diego

机构信息

Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1423-1432. doi: 10.1007/s00417-017-3667-0. Epub 2017 Apr 10.

DOI:10.1007/s00417-017-3667-0
PMID:28396946
Abstract

BACKGROUND

To analyze the pattern and causes of visual loss in patients with Behçet's uveitis and to report on the short-term outcome at 6 months and at last follow-up visit. Also, to analyze the pattern of visual acuity changes in eyes with and without macular involvement at the specified time points.

METHODS

This is a retrospective cohort study of a single-center in an academic practice. Fifty-three patients with Behçet's uveitis evaluated between 2004 and 2014 were included. Data on patients diagnosed with Behçet's uveitis were entered retrospectively into a database and analyzed.

RESULTS

Included were 93 eyes with Behçet's uveitis involving the posterior segment. Frequencies of ≤20/50 and of ≤20/200 VA at presentation were 23.7% and 37.6%, respectively. Retinitis, macular inflammatory infiltrate, and dense vitritis were significantly associated with worse vision. Eyes with macular atrophy and macular inflammatory infiltrate sustained the worst logMAR VA at presentation (1.87 and 1.73, respectively) compared to eyes with cystoid macular edema and epiretinal membrane (0.76 and 0.63, respectively). Eyes with no macular involvement had the best VA at presentation. Mean difference in logMAR VA between presentation and the specified time points was greatest for eyes with macular inflammatory infiltrate.

CONCLUSIONS

Behçet's disease affected mostly young males with a male-to-female ratio of 4.8:1. Panuveitis and posterior uveitis were the predominant forms and they were intrinsically associated with sight-threatening potential and breadth of ocular complications for which aggressive immunosuppressive therapy was essential.

摘要

背景

分析白塞氏葡萄膜炎患者视力丧失的模式及原因,并报告6个月时和末次随访时的短期结局。同时,分析在特定时间点有或无黄斑受累的眼睛的视力变化模式。

方法

这是一项在学术机构单中心进行的回顾性队列研究。纳入了2004年至2014年间评估的53例白塞氏葡萄膜炎患者。将诊断为白塞氏葡萄膜炎患者的数据回顾性录入数据库并进行分析。

结果

纳入93只患有累及后段的白塞氏葡萄膜炎的眼睛。就诊时视力≤20/50和≤20/200的频率分别为23.7%和37.6%。视网膜炎、黄斑炎性浸润和浓密玻璃体炎与较差视力显著相关。与黄斑囊样水肿和视网膜前膜的眼睛相比(分别为0.76和0.63),黄斑萎缩和黄斑炎性浸润的眼睛在就诊时维持最差的最小分辨角对数视力(分别为1.87和1.73)。无黄斑受累的眼睛在就诊时视力最佳。黄斑炎性浸润的眼睛在就诊时与特定时间点之间最小分辨角对数视力的平均差异最大。

结论

白塞氏病主要影响年轻男性,男女比例为4.8:1。全葡萄膜炎和后葡萄膜炎是主要形式,它们本质上与威胁视力的可能性和眼部并发症的广度相关,积极的免疫抑制治疗对此至关重要。

相似文献

1
Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.白塞氏葡萄膜炎视力丧失的模式及原因:短期和长期预后
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1423-1432. doi: 10.1007/s00417-017-3667-0. Epub 2017 Apr 10.
2
Spectrum of Behçet's disease in the Indian population.印度人群中的白塞病谱系
Int Ophthalmol. 2009 Dec;29(6):495-501. doi: 10.1007/s10792-008-9273-8. Epub 2008 Oct 21.
3
[Clinical features of patients with Behcet's uveitis].[白塞氏葡萄膜炎患者的临床特征]
Zhonghua Yan Ke Za Zhi. 2020 Mar 11;56(3):217-223. doi: 10.3760/cma.j.issn.0412-4081.2020.03.010.
4
Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease.白塞病眼部发作评分24与白塞病患者的视力预后
Br J Ophthalmol. 2016 Jul;100(7):990-994. doi: 10.1136/bjophthalmol-2015-307362. Epub 2015 Nov 9.
5
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.贝赫切特综合征相关性葡萄膜炎的长期预后:一项意大利单中心经验。
Mediators Inflamm. 2020 May 15;2020:6872402. doi: 10.1155/2020/6872402. eCollection 2020.
6
Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.泰国人群中 Behçet 葡萄膜炎的眼部表现和视觉结果。
Ocul Immunol Inflamm. 2019;27(1):2-6. doi: 10.1080/09273948.2017.1351570. Epub 2017 Oct 11.
7
Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.北非突尼斯一家转诊中心白塞病患者的葡萄膜炎模式
Int Ophthalmol. 2009 Jun;29(3):135-41. doi: 10.1007/s10792-008-9203-9. Epub 2008 Mar 26.
8
[Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].[肿瘤坏死因子-α拮抗剂及其他免疫调节剂治疗白塞病眼部表现和HLA B51阳性血管炎患者的疗效]
Vojnosanit Pregl. 2012 Feb;69(2):168-74. doi: 10.2298/vsp1202168z.
9
Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.阿达木单抗治疗重度白塞氏葡萄膜炎:一项回顾性长期随访研究。
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S58-62. Epub 2014 Jul 8.
10
[Association between optical coherence tomography findings and visual acuity of Behcet's disease-associated uveitis patients during remission stage].[白塞病相关葡萄膜炎患者缓解期光学相干断层扫描结果与视力的相关性]
Zhonghua Yan Ke Za Zhi. 2015 Oct;51(10):746-9.

引用本文的文献

1
A Meta-Analysis of the Efficacy and Safety of the 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis.0.19毫克醋酸氟轻松植入剂治疗非感染性葡萄膜炎疗效与安全性的Meta分析
Biomedicines. 2025 Jan 21;13(2):248. doi: 10.3390/biomedicines13020248.
2
Ocular involvement in pediatric Behçet's disease: is it different than in adults? (a short case series and mini review).儿童贝赫切特病的眼部受累:与成人有何不同?(一个短篇病例系列和综述)。
BMC Ophthalmol. 2023 Nov 21;23(1):474. doi: 10.1186/s12886-023-03197-5.
3
Optimizing glucocorticoid therapy for Behçet's uveitis: efficacy, adverse effects, and advances in combination approaches.

本文引用的文献

1
Uveitis in Behçet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group.25年来三级医疗中心白塞病患者的葡萄膜炎:KKESH葡萄膜炎调查研究组
Am J Ophthalmol. 2015 Jan;159(1):177-84.e1-2. doi: 10.1016/j.ajo.2014.10.013. Epub 2014 Oct 22.
2
Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab.贝赫切特病眼表评分 24:英夫利昔单抗治疗前后眼表疾病活动的评估。
Jpn J Ophthalmol. 2014 Mar;58(2):120-30. doi: 10.1007/s10384-013-0294-0. Epub 2014 Jan 31.
3
Comparison of presenting features and three-year disease course in Turkish patients with Behçet uveitis who presented in the early 1990s and the early 2000s.
优化贝赫切特葡萄膜炎的糖皮质激素治疗:疗效、不良反应及联合治疗方法的进展。
Int Ophthalmol. 2023 Nov;43(11):4373-4381. doi: 10.1007/s10792-023-02808-w. Epub 2023 Jul 7.
4
Pattern and Visual Prognostic Factors of Behcet's Uveitis in Northwest Iran.伊朗西北部白塞氏葡萄膜炎的发病模式及视觉预后因素
J Ophthalmic Vis Res. 2022 Apr 29;17(2):242-251. doi: 10.18502/jovr.v17i2.10796. eCollection 2022 Apr-Jun.
5
Fluorescein angiographic findings and Behcet's disease ocular attack score 24 (BOS24) as prognostic factors for visual outcome in patients with ocular Behcet's disease.荧光素血管造影结果和白塞病眼部发作评分24(BOS24)作为白塞病性葡萄膜炎患者视力预后的预测因素。
Int J Retina Vitreous. 2021 Aug 28;7(1):48. doi: 10.1186/s40942-021-00318-4.
比较 20 世纪 90 年代初和 21 世纪初就诊的土耳其 Behcet 葡萄膜炎患者的临床表现和三年疾病进程。
Ocul Immunol Inflamm. 2012 Dec;20(6):423-8. doi: 10.3109/09273948.2012.713159. Epub 2012 Nov 19.
4
Behçet disease: visual prognosis and factors influencing the development of visual loss.白塞病:视觉预后和影响视力丧失发展的因素。
Am J Ophthalmol. 2011 Dec;152(6):1059-66. doi: 10.1016/j.ajo.2011.05.032. Epub 2011 Aug 26.
5
Behçet's Uveitis.白塞氏葡萄膜炎
Middle East Afr J Ophthalmol. 2009 Oct;16(4):219-24. doi: 10.4103/0974-9233.58425.
6
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.白塞病中的眼部炎症:眼部并发症及视力丧失的发生率
Am J Ophthalmol. 2008 Dec;146(6):828-36. doi: 10.1016/j.ajo.2008.06.019. Epub 2008 Aug 16.
7
Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.北非突尼斯一家转诊中心白塞病患者的葡萄膜炎模式
Int Ophthalmol. 2009 Jun;29(3):135-41. doi: 10.1007/s10792-008-9203-9. Epub 2008 Mar 26.
8
EULAR recommendations for the management of Behçet disease.欧洲抗风湿病联盟(EULAR)关于白塞病管理的建议。
Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31.
9
Clinical features of chinese patients with Behçet's disease.中国白塞病患者的临床特征。
Ophthalmology. 2008 Feb;115(2):312-318.e4. doi: 10.1016/j.ophtha.2007.04.056. Epub 2007 Aug 10.
10
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.用于报告临床数据的葡萄膜炎命名标准化。第一次国际研讨会的结果。
Am J Ophthalmol. 2005 Sep;140(3):509-16. doi: 10.1016/j.ajo.2005.03.057.